China November foreign exchange reserves increase more than expected
![China November foreign exchange reserves increase more than expected](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
China foreign-exchange reserves increased more than expected in November, according to official data released Monday. The country’s hoard of foreign… Read More »
RCEP enjoys preferential tariffs, why value the product “ID card”?
![RCEP enjoys preferential tariffs, why value the product “ID card”?](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
Products to enjoy tariff preferences must meet the rules of origin. One of the most important breakthroughs of RCEP is… Read More »
AnHui DailyEconomic Contracting and Operating RCEP Series Website
![AnHui DailyEconomic Contracting and Operating RCEP Series Website](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
With the official signing of RCEP on the 15th, economic and trade investment in the region will usher in a… Read More »
V1 Group Formal Entry Into Sanya To Seize New Opportunities of Hainan Free Trade Port Policy and To Capture New Development
![V1 Group Formal Entry Into Sanya To Seize New Opportunities of Hainan Free Trade Port Policy and To Capture New Development](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
One of China’s top 100 internet companies, V1 Group Limited (“V1 Group” or the “Company”, together with its subsidiaries, the… Read More »
Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index
![Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB),… Read More »
China’s First Trastuzumab Biosimilar Approved by NMPA
![China's First Trastuzumab Biosimilar Approved by NMPA](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
Shanghai Henlius Biotech, Inc. (2696.HK) announced on August 14 that the trastuzumab biosimilar HLX02, developed and manufactured by Henlius independently,… Read More »
First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody
![First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
Ascletis Pharma Inc. (HKEX code: 1672) announces today dosing of the first HBV patient in Phase IIa clinical trial of… Read More »
MOVADO launches Ronghao Li as the newest MOVADO Global Ambassador
![MOVADO launches Ronghao Li as the newest MOVADO Global Ambassador](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
MOVADO, Swiss Made Brand founded in 1881, is proud to announce the partnership with award winning A-LIST Chinese musician Ronghao… Read More »
ZTE to launch the world’s first 5G smartphone with under-display camera on September 1, 2020
![ZTE to launch the world's first 5G smartphone with under-display camera on September 1, 2020](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
ZTE Corporation (0763.HK/000063,SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the mobile internet, today announced… Read More »
XCMG’s Semiannual Report Shows 17 Percent Main Business Revenue Growth
![XCMG's Semiannual Report Shows 17 Percent Main Business Revenue Growth](https://www.businessnews.com.cn/wp-content/themes/proxima/images/thumbnail-placeholder.gif)
XCMG (SZ:000425) has achieved a sales revenue growth rate of 17 percent year-on-year, according to its semiannual report to release… Read More »